At5g05820 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to At5g05820 Antibody

The At5g05820 Antibody (Product Code: CSB-PA724888XA01DOA) is a polyclonal rabbit-derived antibody specifically designed to target the protein encoded by the At5g05820 gene in Arabidopsis thaliana. This antibody is primarily used for detecting and analyzing the corresponding protein in experimental settings, such as Western Blot (WB) and Enzyme-Linked Immunosorbent Assay (ELISA). Its development aligns with broader efforts to study gene expression, protein localization, and functional roles in plant biology, particularly in the model organism Arabidopsis .

Western Blot (WB)

The At5g05820 Antibody is optimized for detecting the At5g05820 protein in Arabidopsis lysates. Its polyclonal nature ensures broad epitope recognition, enhancing sensitivity for protein identification .

ELISA

This antibody can be used in ELISA assays to quantify At5g05820 protein levels in Arabidopsis extracts. Its compatibility with enzymatic tags (e.g., horseradish peroxidase) enables high-throughput screening .

Antigen Selection

The antibody was raised against a recombinant At5g05820 protein, ensuring specificity for the target. This approach minimizes cross-reactivity with non-target proteins in Arabidopsis .

Purification and Clonality

  • Purification: Antigen affinity chromatography ensures high purity and binding specificity.

  • Clonality: Polyclonal antibodies recognize multiple epitopes, improving detection robustness compared to monoclonal alternatives .

Research Findings and Potential Applications

While specific studies using the At5g05820 Antibody are not detailed in publicly available literature, its design aligns with established methods for studying gene function in Arabidopsis. For example:

Hypothetical Use Cases

  1. Gene Expression Analysis

    • Quantifying At5g05820 protein levels in developmental or stress-response studies.

    • Comparing expression across Arabidopsis tissues (e.g., leaves, roots).

  2. Protein Localization

    • Identifying subcellular localization patterns using immunofluorescence (if conjugated to fluorescent tags).

  3. Functional Studies

    • Investigating interactions with other proteins via co-immunoprecipitation (IP).

Limitations and Considerations

  • Cross-Reactivity: Polyclonal antibodies may bind non-target proteins. Validation with negative controls (e.g., At5g05820-knockout plants) is critical .

  • Batch Variability: Differences in antibody performance between production batches require consistent testing .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At5g05820 antibody; MJJ3.24 antibody; Probable sugar phosphate/phosphate translocator At5g05820 antibody
Target Names
At5g05820
Uniprot No.

Target Background

Database Links

KEGG: ath:AT5G05820

STRING: 3702.AT5G05820.1

UniGene: At.43263

Protein Families
TPT transporter family, TPT (TC 2.A.7.9) subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is the At5g05820 gene and why is it significant for antibody development?

At5g05820 is a gene locus in Arabidopsis thaliana that encodes a protein involved in plant developmental processes and stress responses. Developing antibodies against this protein is critical for studying its expression patterns, subcellular localization, and functional interactions in plant tissues. The protein's involvement in fundamental plant processes makes it a valuable target for immunological detection methods aimed at understanding plant cellular mechanisms.

Researchers typically develop both polyclonal and monoclonal antibodies against specific epitopes of the At5g05820 protein product. These antibodies enable visualization of expression patterns across different tissues, developmental stages, and in response to various environmental stimuli. The development process involves careful epitope selection to ensure specificity while maintaining functional detection capacity across experimental conditions .

How is the specificity of At5g05820 antibodies validated?

Validating antibody specificity is essential for ensuring experimental reliability. For At5g05820 antibodies, validation should include multiple complementary approaches:

  • Genetic validation: Testing antibody reactivity in At5g05820 knockout or knockdown lines, which should show absent or significantly reduced signal compared to wild-type plants.

  • Western blot analysis: Confirming detection of a single band at the expected molecular weight, with additional validation using recombinant protein standards.

  • Peptide competition assays: Pre-incubating the antibody with immunizing peptide should abolish signal in subsequent applications.

  • Cross-reactivity testing: Evaluating potential cross-reactivity with closely related proteins to ensure signal specificity.

  • Mass spectrometry validation: Confirming that immunoprecipitated proteins correspond to At5g05820 through LC-MS/MS analysis .

What are the critical differences between polyclonal and monoclonal antibodies for At5g05820 research?

CharacteristicPolyclonal AntibodiesMonoclonal AntibodiesResearch Implications
Epitope recognitionMultiple epitopesSingle epitopeMonoclonals provide consistent epitope targeting
Production methodImmunized animals (typically rabbits)Hybridoma technology (typically rats or mice)Monoclonals offer unlimited supply of identical antibodies
Batch consistencySignificant batch-to-batch variationHigh consistency between batchesMonoclonals provide better experimental reproducibility
SensitivityGenerally higher sensitivityMay have lower sensitivityPolyclonals may detect lower abundance targets
ApplicationsExcellent for initial detectionPreferred for specific epitope targetingApplication-dependent selection required
Cross-reactivityHigher potential for cross-reactivityMore specific bindingMonoclonals reduce false positives in complex samples

The choice between polyclonal and monoclonal antibodies should be guided by experimental requirements. Novel monoclonal antibody development techniques, such as those used for plant epitopes, can provide highly specific reagents for At5g05820 detection . Monoclonal antibodies often require extensive screening processes to identify clones with optimal specificity and sensitivity characteristics .

What are the optimal assay conditions for using At5g05820 antibodies in plant tissue immunohistochemistry?

Successful immunohistochemistry with At5g05820 antibodies requires careful optimization of multiple parameters:

Sample preparation protocol:

  • Fix plant tissues in 4% paraformaldehyde in PBS for 2-4 hours

  • Dehydrate through an ethanol series (30%, 50%, 70%, 85%, 95%, 100%)

  • Clear with xylene or alternative clearing agents

  • Embed in paraffin and section at 8-10 μm thickness

  • Mount on positively-charged slides

Antigen retrieval methods:

  • Heat-induced epitope retrieval using citrate buffer (pH 6.0) at 95°C for 20 minutes

  • Enzymatic retrieval using proteinase K (1-5 μg/ml for 5-15 minutes)

  • Optimization is critical as over-retrieval can damage tissue morphology

Blocking and antibody incubation:

  • Block with 5% normal serum and 0.3% Triton X-100 in PBS for 1 hour

  • Incubate with primary At5g05820 antibody (typically 1:100-1:500 dilution) overnight at 4°C

  • Wash 3× with PBS containing 0.1% Tween-20

  • Incubate with appropriate secondary antibody for 1-2 hours at room temperature

  • Wash 3× with PBS containing 0.1% Tween-20

  • Counterstain and mount appropriately

Each step requires careful optimization for the specific tissue type and fixation method used. The dilution and incubation conditions may need adjustment based on antibody affinity and target abundance .

How should At5g05820 antibodies be stored to maintain long-term efficacy?

Proper storage is critical for maintaining antibody functionality over time:

Storage recommendations:

  • Store unconjugated antibodies at -20°C in small aliquots to minimize freeze-thaw cycles

  • For conjugated antibodies, follow manufacturer recommendations (typically 2-8°C protected from light)

  • Avoid repeated freeze-thaw cycles by preparing appropriately sized single-use aliquots

  • Include a protein carrier (0.1-0.5% BSA) and preservative (0.02-0.05% sodium azide) in storage buffer

Stability monitoring:

  • Test antibody performance periodically against a reference sample

  • Document lot numbers and performance characteristics

  • Consider implementing a quality control program for critical antibodies

Reconstitution guidelines:

  • Centrifuge vials briefly before opening

  • Allow to equilibrate to room temperature before opening to prevent condensation

  • Reconstitute lyophilized antibodies precisely according to manufacturer instructions

Following storage recommendations similar to those for other research antibodies, such as storing working solutions at 4°C protected from light and avoiding freezing of conjugated antibodies, will help maintain efficacy .

What advanced techniques can improve detection sensitivity for low-abundance At5g05820 protein?

When studying low-abundance At5g05820 protein, several signal amplification techniques can significantly improve detection:

Signal amplification methods:

  • Tyramide Signal Amplification (TSA): Provides 10-100× signal enhancement through catalyzed reporter deposition

  • DELFIA (Dissociation-Enhanced Lanthanide Fluorescence Immunoassay): Utilizes time-resolved fluorescence to reduce background and increase sensitivity

  • Proximity Ligation Assay (PLA): Enables detection of protein interactions with single-molecule sensitivity

  • Polymer-based detection systems: Multiple secondary antibodies on a polymer backbone enhance signal without increasing background

Sample enrichment strategies:

  • Subcellular fractionation to concentrate target compartments

  • Immunoprecipitation followed by Western blotting

  • Protein concentration techniques prior to analysis

Assay optimization for low abundance targets:

  • Extended primary antibody incubation (overnight at 4°C)

  • Increased antibody concentration (empirically determined)

  • Reduction of detergent concentration in washing buffers

  • Use of high-sensitivity substrates for enzymatic detection

DELFIA assays offer particular advantages for low-abundance targets due to their wide dynamic range and low background, making them suitable for detecting even small amounts of At5g05820 protein in complex plant tissue samples .

How can non-specific binding be reduced when using At5g05820 antibodies in plant tissues?

Non-specific binding is a common challenge in plant tissue immunoassays that can be addressed through several strategies:

Blocking optimization:

  • Test different blocking agents (BSA, casein, normal serum from secondary antibody host species)

  • Extend blocking time (2 hours at room temperature or overnight at 4°C)

  • Consider dual blocking strategies (protein blocker followed by irrelevant IgG)

Buffer modifications:

  • Increase salt concentration (150-500 mM NaCl) to reduce ionic interactions

  • Optimize detergent type and concentration (0.1-0.3% Triton X-100 or Tween-20)

  • Add 1-5% polyethylene glycol to reduce hydrophobic interactions

Antibody preparation:

  • Pre-adsorb antibody against plant tissue from knockout lines

  • Use affinity-purified antibody preparations

  • Perform cross-adsorption against related plant proteins

Protocol refinements:

  • Increase washing stringency (duration, detergent concentration)

  • Optimize antibody dilution to minimize background while maintaining specific signal

  • Consider alternative fixation methods that better preserve epitope while reducing background

Implementing these strategies systematically, similar to approaches used in monoclonal antibody development for plant antigens, can significantly improve signal-to-noise ratio in At5g05820 detection assays .

What approaches can resolve contradictory results from different At5g05820 antibody experiments?

When faced with contradictory results from At5g05820 antibody experiments, a systematic investigation approach is essential:

Methodological considerations:

  • Epitope differences: Different antibodies may recognize different epitopes that could be differentially accessible depending on protein conformation or interactions

  • Assay-specific limitations: Results from different methods (e.g., Western blot vs. immunohistochemistry) may reflect methodological differences rather than biological contradictions

  • Sample preparation effects: Different fixation or extraction protocols may affect epitope accessibility

Experimental design evaluation:

  • Assess control adequacy (positive, negative, and isotype controls)

  • Compare normalization methods and quantification approaches

  • Evaluate statistical power and sample sizes

Reconciliation strategies:

Contradiction TypeInvestigation ApproachResolution Strategy
Presence/AbsenceTest with multiple antibodies recognizing different epitopesConfirm with genetic approaches (knockout/knockdown)
Localization differencesCompare fixation and permeabilization methodsUse epitope-tagged versions for validation
Quantitative differencesAnalyze dynamic range of different assay methodsApply absolute quantification using standard curves
Temporal/spatial discrepanciesExamine developmental timing and tissue specificityDesign time-course and tissue-specific experiments

Systematic comparison of results obtained with different antibodies, similar to approaches used for pectic homogalacturonan epitope characterization, can help identify the source of contradictions and resolve apparent discrepancies .

How can At5g05820 antibodies be incorporated into multiplex detection systems?

Multiplex detection allows simultaneous analysis of At5g05820 along with other proteins of interest, providing valuable contextual information:

Immunofluorescence multiplexing strategies:

  • Primary antibodies from different host species: Use species-specific secondary antibodies with distinct fluorophores

  • Directly conjugated primary antibodies: Eliminate secondary antibody cross-reactivity concerns

  • Sequential staining protocols: Complete labeling with one antibody before blocking and applying the next

  • Spectral unmixing techniques: Computational separation of overlapping fluorescent signals

Flow cytometry applications:

  • Combine At5g05820 antibody with markers for different cell types or cellular states

  • Use fluorophores with minimal spectral overlap

  • Include proper compensation controls

Experimental considerations for successful multiplexing:

Multiplexing ChallengeSolutionImplementation Note
Cross-reactivityTest each antibody individually firstEstablish single-plex protocols before combining
Signal interferenceChoose compatible fluorophores or enzyme systemsConsider brightness, spectral separation, and potential energy transfer
Epitope accessibilityOptimize antigen retrieval for multiple targetsMay require compromise conditions suitable for all targets
Analysis complexityUse appropriate controls for each targetInclude single-stained samples for compensation

Flow cytometry applications with antibodies like the PerCP-Cy5.5 conjugated antibody described in the search results demonstrate how proper fluorophore selection and protocol optimization can enable successful multiplex detection .

What are the recommended normalization methods for quantitative At5g05820 antibody data?

Proper normalization is essential for meaningful comparisons of At5g05820 expression across different samples:

Western blot normalization approaches:

  • Housekeeping protein normalization: Normalize to stable reference proteins (e.g., actin, tubulin)

  • Total protein normalization: Use stain-free gels or total protein stains (Ponceau S, SYPRO Ruby)

  • Loading control peptides: Spike-in synthetic peptides for absolute quantification

Immunohistochemistry quantification:

  • Relative measurement: Compare signal intensity to internal control regions

  • Cell-type specific normalization: Normalize to cell-type specific markers

  • Standardized acquisition: Use identical imaging parameters across all samples

ELISA and immunoassay normalization:

  • Standard curve calibration: Generate standard curves with purified At5g05820 protein

  • Parallel line analysis: Compare dose-response curves between samples and standards

  • Internal controls: Include reference samples in each assay plate

The wide dynamic range of DELFIA immunoassays makes them particularly suitable for quantitative analysis of At5g05820 across samples with varying expression levels .

How should researchers account for post-translational modifications when interpreting At5g05820 antibody results?

Post-translational modifications (PTMs) can significantly affect antibody binding and must be considered when interpreting results:

Common PTMs affecting antibody recognition:

  • Phosphorylation

  • Glycosylation

  • Ubiquitination

  • Proteolytic processing

  • Conformational changes

Experimental approaches to address PTM concerns:

  • Epitope-specific antibodies: Use antibodies that specifically recognize modified or unmodified forms

  • Enzymatic treatments: Treat samples with phosphatases, glycosidases, or other enzymes to remove specific modifications

  • Mobility shift analysis: Compare migration patterns before and after enzymatic treatment

  • Modification-specific detection methods: Use PTM-specific stains or antibodies in parallel

Interpretation strategies:

ObservationPossible PTM ExplanationVerification Approach
Multiple bands in Western blotDifferent modification states or proteolytic processingEnzymatic treatment to remove modifications
Differential detection across tissuesTissue-specific modification patternsCompare with modification-specific antibodies
Altered signal after treatmentsInduced modifications affecting epitope accessibilityPre-treat samples to remove modifications
Subcellular localization differencesCompartment-specific modificationsCo-localization with modification-specific markers

Understanding the potential impact of PTMs on antibody binding is crucial for accurate interpretation of At5g05820 detection results, particularly when comparing results across different experimental conditions or tissue types .

What statistical approaches are most appropriate for analyzing variability in At5g05820 antibody experiments?

Sources of variability in At5g05820 antibody experiments:

  • Technical variation (antibody performance, protocol execution)

  • Biological variation (sample heterogeneity, developmental factors)

  • Instrument variation (detection sensitivity, calibration differences)

Statistical approaches for robust analysis:

  • Power analysis: Determine appropriate sample size before experiments

  • Nested design analysis: Account for technical replicates within biological replicates

  • Mixed-effects models: Separate fixed effects (experimental treatments) from random effects (batch variation)

  • Non-parametric methods: For data that does not meet normality assumptions

  • Multiple comparison corrections: Control family-wise error rate or false discovery rate

Experimental design recommendations:

Research QuestionDesign RecommendationStatistical Approach
Expression comparison across genotypesBalanced design with matched controlsANOVA with post-hoc tests
Developmental time courseLongitudinal sampling with internal controlsRepeated measures analysis
Treatment responseInclude dose-response relationshipsRegression analysis
Localization patternsQuantitative image analysis with multiple fieldsMixed models with spatial components

Reporting standards:

  • Clearly describe normalization methods

  • Report both technical and biological replication

  • Include measures of variability (standard deviation, confidence intervals)

  • Provide raw data when possible

How can CRISPR-based approaches complement At5g05820 antibody studies?

CRISPR technology offers powerful complementary approaches to traditional antibody-based detection of At5g05820:

Genome editing applications:

  • Knockout validation: Generate complete At5g05820 knockout lines for definitive antibody validation

  • Epitope tagging: Add endogenous tags (FLAG, HA, GFP) to enable detection with validated tag antibodies

  • Reporter knock-ins: Insert fluorescent protein coding sequences for direct visualization

  • Allelic series: Create mutations affecting specific protein domains to correlate with antibody binding

Advantages over traditional antibody approaches:

  • Endogenous expression levels maintain physiological relevance

  • Tag-based detection eliminates concerns about antibody specificity

  • Visualization possible in live tissues without fixation artifacts

  • Enables temporal and spatial expression studies with minimal perturbation

Experimental considerations:

ApplicationAdvantagesLimitationsImplementation Notes
C-terminal taggingMaintains endogenous regulationMay disrupt C-terminal functionsTest multiple tag positions
N-terminal taggingAvoids disrupting C-terminal motifsMay affect signal peptide functionConsider internal tagging if termini are functional
Knock-in reportersDirect visualization without antibodiesMay alter protein functionUse self-cleaving peptides to separate tag from protein
Conditional allelesTemporal and spatial controlMore complex designCombine with tissue-specific Cre/lox systems

These approaches can provide valuable complementary data to traditional antibody-based studies, particularly when antibody specificity is challenging to validate or when dynamic processes need to be studied in living tissues.

What are the cutting-edge mass spectrometry approaches for validating At5g05820 antibody specificity?

Advanced mass spectrometry techniques provide powerful tools for antibody validation:

Mass spectrometry validation approaches:

  • Immunoprecipitation-mass spectrometry (IP-MS): Verify that antibodies capture the intended target protein

  • Parallel reaction monitoring (PRM): Targeted analysis of specific At5g05820 peptides

  • Data-independent acquisition (DIA): Comprehensive analysis of all detectable peptides

  • Cross-linking mass spectrometry (XL-MS): Map epitope-paratope interactions

Workflow for antibody validation by mass spectrometry:

  • Immunoprecipitate target protein using the antibody

  • Process samples for proteomic analysis (reduction, alkylation, digestion)

  • Analyze by LC-MS/MS to identify captured proteins

  • Compare identified proteins with expected target sequence

  • Quantify relative abundance of target vs. non-target proteins

Advanced applications:

  • Epitope mapping: Identify the specific peptide sequences recognized by the antibody

  • Cross-reactivity profiling: Identify off-target proteins that share epitope sequences

  • PTM analysis: Determine if modifications affect antibody recognition

  • Absolute quantification: Use isotope-labeled peptide standards for absolute quantification

These mass spectrometry approaches provide objective, sequence-level validation of antibody specificity that complements traditional validation methods and can help resolve contradictory results from different antibodies targeting the same protein.

How will machine learning and computational approaches impact future At5g05820 antibody research?

Emerging computational approaches are transforming antibody research and will significantly impact At5g05820 studies:

Machine learning applications in antibody research:

  • Epitope prediction: Computational identification of optimal antigenic regions of At5g05820

  • Cross-reactivity prediction: Algorithms to predict potential off-target binding

  • Image analysis automation: Deep learning for quantitative analysis of immunohistochemistry

  • Structure prediction: Modeling antibody-antigen interactions through AlphaFold-type approaches

Data integration platforms:

  • Integration of antibody-based data with transcriptomics and proteomics

  • Network analysis to place At5g05820 in functional context

  • Automated literature mining to synthesize published findings

Impact on experimental design and analysis:

Research PhaseComputational ApproachExpected Impact
Antibody designEpitope prediction algorithmsMore specific antibodies with reduced cross-reactivity
ValidationAutomated image analysisHigher throughput, more objective assessment
Data analysisPattern recognition in complex datasetsDetection of subtle phenotypes and correlations
Literature reviewNatural language processingComprehensive synthesis of published results

These computational approaches will enable more efficient antibody development, more objective data analysis, and more comprehensive integration of At5g05820 research with broader plant biology knowledge.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.